Japanese Drug Co. To Pay $736M For US Generics Maker
A top Japanese generic-drug maker announced on Monday it was taking its first steps into the U.S. market with the $736 million acquisition of an Illinois-based counterpart....To view the full article, register now.
Already a subscriber? Click here to view full article